{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T07:29:11Z","timestamp":1786519751111,"version":"build-2736575974"},"reference-count":20,"publisher":"Danish Medical Association","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dan Med J"],"abstract":"<jats:p>INTRODUCTION. Chronic graft-versus-host disease (cGVHD) impairs quality of life after allogeneic haematopoietic stem cell transplantation. This study aimed to translate the Lee cGVHD Symptom Scale, a validated patient-reported outcome measure, into Danish and evaluate its psychometric properties.\n\nMETHODS. The scale was translated using forward\u2013backward translation and cognitive debriefing interviews. Questionnaire data from the Danish version were collected at baseline and after 7-10 days. Construct validity was assessed with exploratory factor analysis (EFA), convergent and divergent validity by correlations with the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30) and the Common Terminology of Cancer-related Adverse Events (PRO-CTCAE). Internal consistency was assessed using Cronbach\u2019s alpha, and test-retest reliability using intraclass correlation coefficients (ICC).\nRESULTS. A total of 72 patients participated; 65 completed the test-retest. EFA supported a six-factor structure, with some deviations from the original subscales. Cronbach\u2019s alpha for the total scale was good (0.86). The test-retest ICC ranged from 0.23 to 0.93. Most hypothesised correlations for convergent and divergent validity were confirmed.\n\nCONCLUSIONS. The Danish Lee cGVHD Symptom Scale is a valid and reliable instrument for assessing cGVHD symptoms. Overall consistency and reliability were acceptable, though refinement of some subscales is recommended. The scale is suitable for both clinical and research use in Danish cGVHD populations, with further validation suggested in larger samples.\nFUNDING. The Joint Research Fund of Odense University Hospital and Rigshospitalet. Funding no.: 83-A3982.\n\nTRIAL REGISTRATION. Not relevant.<\/jats:p>","DOI":"10.61409\/a09250759","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T06:57:07Z","timestamp":1779346627000},"page":"1-10","source":"Crossref","is-referenced-by-count":0,"title":["Translation and validation of the Lee Chronic Graft-versus-Host Disease Symptom Scale in Denmark"],"prefix":"10.61409","author":[{"given":"Anne M.","family":"Clausen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian T.","family":"Kornblit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria T.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duruta","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tine","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas K.","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Alfaro-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Jarden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"40208","published-online":{"date-parts":[[2026,5]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Lee CJ, Wang T, Chen K, et al. Severity of chronic graft-versus-host disease and late effects following allogeneic hematopoietic cell transplantation for adults with hematologic malignancy. Transplant Cell Ther. 2024;30(1):97.e1-97.e14. https:\/\/doi.org\/10.1016\/j.jtct.2023.10.010","DOI":"10.1016\/j.jtct.2023.10.010"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"DeFilipp Z, Alousi AM, Pidala JA, et al. Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the Chronic GVHD Consortium. Blood Adv. 2021;5(20):4278-4284. https:\/\/doi.org\/10.1182\/bloodadvances.2021004941","DOI":"10.1182\/bloodadvances.2021004941"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Baumrin E, Loren AW, Falk SJ, et al. Chronic graft-versus-host disease. Part I: Epidemiology, pathogenesis, and clinical manifestations. J Am Acad Dermatol. 2024;90(1):1-16. https:\/\/doi.org\/10.1016\/j.jaad.2022.12.024","DOI":"10.1016\/j.jaad.2022.12.024"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"El-Jawahri A, Pidala J, Khera N, et al. Impact of psychological distress on quality of life, functional status, and survival in patients with chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2018;24(11):2285-2292. https:\/\/doi.org\/10.1016\/j.bbmt.2018.07.020","DOI":"10.1016\/j.bbmt.2018.07.020"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Wenzel F, Pralong A, Scheid C, et al. Burden, resources, and needs of patients with severe graft-versus-host disease - a qualitative study. Palliat Support Care. 2025;23:e69. https:\/\/doi.org\/10.1017\/S147895152400172X","DOI":"10.1017\/S147895152400172X"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Gruber I, Koelbl O, Herr W, et al. Impact of chronic graft-versus-host disease on quality of life and cognitive function of long-term transplant survivors after allogeneic hematopoietic stem cell transplantation with total body irradiation. Radiat Oncol. 2022;17(1):195. https:\/\/doi.org\/10.1186\/s13014-022-02161-9","DOI":"10.1186\/s13014-022-02161-9"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Hansen JL, Juckett MB, Foster MA, et al. Psychological and physical function in allogeneic hematopoietic cell transplant survivors with chronic graft-versus-host disease. J Cancer Surviv. 2023;17(3):646-656. https:\/\/doi.org\/10.1007\/s11764-023-01354-9","DOI":"10.1007\/s11764-023-01354-9"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Kurosawa S, Yamaguchi T, Oshima K, et al. Resolved versus active chronic graft-versus-host disease: impact on post-transplantation quality of life. Biol Blood Marrow Transplant. 2019;25(9):1851-1858. https:\/\/doi.org\/10.1016\/j.bbmt.2019.05.016","DOI":"10.1016\/j.bbmt.2019.05.016"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Merkel EC, Mitchell SA, Lee SJ. Content validity of the Lee Chronic Graft-versus-Host Disease Symptom Scale as assessed by cognitive interviews. Biol Blood Marrow Transplant. 2016;22(4):752-758. https:\/\/doi.org\/10.1016\/j.bbmt.2015.12.026","DOI":"10.1016\/j.bbmt.2015.12.026"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Teh C, Onstad L, Lee SJ. Reliability and validity of the modified 7-Day Lee Chronic Graft-versus-Host Disease Symptom Scale. Biol Blood Marrow Transplant. 2020;26(3):562-567. https:\/\/doi.org\/10.1016\/j.bbmt.2019.11.020","DOI":"10.1016\/j.bbmt.2019.11.020"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Lee SJ, Wolff D, Kitko C, et al. Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report. Biol Blood Marrow Transplant. 2015;21(6):984-999. https:\/\/doi.org\/10.1016\/j.bbmt.2015.02.025","DOI":"10.1016\/j.bbmt.2015.02.025"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Lee SK, Cook EF, Soiffer R, Antin JH. Development and validation of a scale to measure symptoms of chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2002;8(8):444-452. https:\/\/doi.org\/10.1053\/bbmt.2002.v8.pm12234170","DOI":"10.1053\/bbmt.2002.v8.pm12234170"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Wild D, Grove A, Martin M, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health. 2005;8(2):94-104. https:\/\/doi.org\/10.1111\/j.1524-4733.2005.04054.x","DOI":"10.1111\/j.1524-4733.2005.04054.x"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res. 2010;19(4):539-549. https:\/\/doi.org\/10.1007\/s11136-010-9606-8","DOI":"10.1007\/s11136-010-9606-8"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap) - a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Kaiser HF. An index of factorial simplicity. Psychometrika. 1974;39(1):31-36. https:\/\/doi.org\/10.1007\/BF02291575","DOI":"10.1007\/BF02291575"},{"key":"ref16","unstructured":"Snedecor GW, Cochran WG. Statistical methods. 6th ed. Ames: Iowa State University Press, 1973"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Nielsen LK, Mercieca-Bebber R, M\u00f6ller S, et al. Relationship between reasons for intermittent missing patient-reported outcomes data and missing data mechanisms. Qual Life Res. 2024;33(9):2387-2400. https:\/\/doi.org\/10.1007\/s11136-024-03707-y","DOI":"10.1007\/s11136-024-03707-y"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Paudel R, Enzinger AC, Uno H, et al. Effects of a change in recall period on reporting severe symptoms: an analysis of a pragmatic multisite trial. J Natl Cancer Inst. 2024;116(7):1137-1144. https:\/\/doi.org\/10.1093\/jnci\/djae049","DOI":"10.1093\/jnci\/djae049"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"de Souza CV, Vigorito AC, Miranda ECM, et al. Translation, cross-cultural adaptation, and validation of the Lee Chronic Graft-versus-Host Disease Symptom Scale in a Brazilian population. Biol Blood Marrow Transplant. 2016;22(7):1313-1318. https:\/\/doi.org\/10.1016\/j.bbmt.2016.03.013","DOI":"10.1016\/j.bbmt.2016.03.013"}],"container-title":["Danish Medical Journal"],"original-title":[],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T06:48:13Z","timestamp":1786517293000},"score":1,"resource":{"primary":{"URL":"https:\/\/ugeskriftet.dk\/dmj\/A09250759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":20,"URL":"https:\/\/doi.org\/10.61409\/a09250759","relation":{},"ISSN":["2245-1919"],"issn-type":[{"value":"2245-1919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}